Demoxytocin
{{chembox
| Verifiedfields = changed
| UNII_Ref =
| UNII = 2N9HM3X95F
| verifiedrevid = 444602345
|ImageFile=Demoxytocin.svg.png
|ImageSize=
|IUPACName= 2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-N-(carbamoylmethyl)-4-methylpentanamide
|OtherNames=
|Section1=! colspan=2 style="background: #f8eaba; text-align: center;" |Identifiers
|-
|
|
|-
| ChEMBL
|
|-
| ECHA InfoCard
| Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
|-
| KEGG
|
|- | MeSH | deaminooxytocin |-
|
|
|-
|Section2=! colspan=2 style="background: #f8eaba; text-align: center;" |Properties
|-
|
| C43H65N11O12S2
|- | Molar mass
| 992.1727
|- |Section3= }}
|
WikiDoc Resources for Demoxytocin |
|
Articles |
|---|
|
Most recent articles on Demoxytocin Most cited articles on Demoxytocin |
|
Media |
|
Powerpoint slides on Demoxytocin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Demoxytocin at Clinical Trials.gov Clinical Trials on Demoxytocin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Demoxytocin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Demoxytocin Discussion groups on Demoxytocin Patient Handouts on Demoxytocin Directions to Hospitals Treating Demoxytocin Risk calculators and risk factors for Demoxytocin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Demoxytocin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Demoxytocin (INN, trade name Sandopart) or deaminooxytocin, is an obstetric drug often used in the prevention of puerperal mastitis. It is an analogue of oxytocin.